ALL vs FDMT · P/E 4.9, $56.89B cap vs rev $37.0K
The Allstate Corporation (ALL) versus 4D Molecular Therapeutics Inc (FDMT) — a side-by-side from cached financials, not a winner call.
The Allstate Corporation (ALL) is a insurance - property & casualty company listed on US.
4D Molecular Therapeutics Inc (FDMT) is a biotechnology company listed on US.
ALL does not have a complete income-statement cache yet.
Latest reported FDMT revenue for 2024-12-31 was $37.0K. Net income was -$160.9M. Revenue was down 99.8% from 2023-12-31 to 2024-12-31. FDMT currently screens at market cap $518.1M.
ALL currently screens at market cap $56.89B and trailing P/E 4.9. FDMT currently screens at market cap $518.1M.
Not investment advice. Open the ALL and FDMT stock pages for the full models.
Not investment advice.